about
Histopathological findings in colorectal liver metastases after electrochemotherapy.Update on the role of imaging in management of metastatic colorectal cancerTime to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III TrialElevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma.The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus.That liver lesion on MDCT in the oncology patient: is it important?Anti-inflammatory liposomes have no impact on liver regeneration in ratsFluorescence-guided surgery of human colon cancer increases complete resection resulting in cures in an orthotopic nude mouse model.KRAS mutation in lung metastases from colorectal cancer: prognostic implications.Early post-operative prediction of morbidity and mortality after a major liver resection for colorectal metastases.A review of 3D image-based dosimetry, technical considerations and emerging perspectives in (90)Y microsphere therapy.Colorectal Liver Metastases: A Never Ending StoryFluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model.Downregulation of osteoprotegerin expression in metastatic colorectal carcinoma predicts recurrent metastasis and poor prognosis.MicroRNAs: relevant tools for a colorectal surgeon?A systematic review of repeat hepatectomy for recurrent colorectal liver metastases.Regional Delivery of Chimeric Antigen Receptor (CAR) T-Cells for Cancer Therapy.Assessment of Liver Remnant Using ICG Clearance Intraoperatively during Vascular Exclusion: Early Experience with the ALIIVE TechniqueMicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer.A Pathway to Personalizing Therapy for Metastases Using Liver-on-a-Chip Platforms.Mucosa-associated invariant T cells infiltrate hepatic metastases in patients with colorectal carcinoma but are rendered dysfunctional within and adjacent to tumor microenvironment.Repeat Hepatectomy for Recurrent Colorectal Liver Metastases: Is it Worth the Challenge?Robot-assisted one-stage resection of rectal cancer with liver and lung metastases.Upregulated WEE1 protects endothelial cells of colorectal cancer liver metastases.Evaluation of YO-PRO-1 as an early marker of apoptosis following radiofrequency ablation of colon cancer liver metastases.Randomized trial of simplified LV5FU2 versus FOLFOX7 followed by FOLFIRI (MIROX) in patients with initially resectable metastatic colorectal cancer: a GERCOR study.Improved disease-free survival and overall survival after fluorescence-guided surgery of liver metastasis in an orthotopic nude mouse model.GSK-3β phosphorylation-dependent degradation of ZNF281 by β-TrCP2 suppresses colorectal cancer progression.Cost-effective imaging for resectability of liver lesions in colorectal cancer: an economic decision model.Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis.Portal branch ligation does not counteract the inhibiting effect of temsirolimus on extrahepatic colorectal metastatic growth.RSK2 phosphorylates T-bet to attenuate colon cancer metastasis and growth.Characterization of Cancer Stem Cells in Colon Adenocarcinoma Metastasis to the Liver.Loss of CDX2 gene expression is associated with DNA repair proteins and is a crucial member of the Wnt signaling pathway in liver metastasis of colorectal cancer.microRNA biomarkers in colorectal cancer liver metastasis
P2860
Q33884224-943DBF6F-D1C0-4D46-881B-58F1DF219D63Q35285305-96AFF3A6-363D-4800-B5C8-975564B592A3Q36054226-8BED56CE-179A-4440-8AD6-067D53B1C699Q36109796-82A4E281-E10B-4D4E-A5F0-102072AE4822Q36349575-0552397B-21CC-413B-AF3A-303F7FAEBA4AQ36361589-15E8DDD2-8EEA-455C-B47D-B69F2AD751D7Q36387936-109DD8E3-4F3C-4CCC-A16E-3FEFE3783209Q36457200-23246388-DDE8-4574-9EF8-6C3C161D12A2Q36528345-99809762-F88B-4FCE-A812-E5D5458101AFQ36786146-CF53C2EA-F0AE-4CE3-9CF2-5E4DD9F30015Q36899620-B6F10481-D098-4631-9D36-B4545DA1D67AQ37088913-442B4B04-7A7C-4041-A5D3-334B81F13C12Q37656283-7F728861-CD41-4528-806A-853B6AF85146Q37694788-C833EE91-31AE-4E9B-BA50-54B3F635F887Q38004774-E1537EF5-B840-4157-A4F3-F34284C2F3C8Q38092734-A2F3AF5D-9719-4255-A2FB-2701FA95283BQ38656009-DAAE13B8-DB1E-4BED-8CC1-124F1FAFC46FQ38992142-0A2EF321-A08D-44CA-B93B-5966A65A46E2Q39090370-A30BFFC1-97D4-4840-A8DF-27336D54B58FQ39251464-10E9599D-E26D-4F5B-A5C9-167CE2E83029Q40097622-1A07C176-48FB-4E77-A9B6-38561BBB556BQ41371947-EF2F8AC0-B105-404A-91BE-8634F7DF5F38Q41789224-7B4D8541-60DC-4804-B2C8-4E5CCA9358BDQ41851539-13FE5DF3-7004-4D5E-A16D-CB5461EA1765Q41934918-C1B08772-39CD-4C63-B74B-DEFB953C934AQ43457248-73FAC771-A466-4238-91E2-05390BE427DFQ45937368-C5288DF9-4B61-4945-889F-71B7DE8A971BQ47101900-3F7746F2-E493-4339-8779-B0436C758FEDQ47660165-A9DF1924-E20D-41C5-84A4-CD4D23C58BCFQ47674225-C7CC380B-C806-4E10-BC95-49A657581C48Q48252909-EC2D972A-B35F-4F6A-9E9C-35B2C85DFEE8Q50042871-89D423AA-8282-416E-8309-8FB204450BE1Q50195553-38BD72E7-5401-42DB-8BBA-1CC9AB5AF7F0Q50232925-98704F53-CE39-4075-8B45-055F661EA40EQ58581359-BA5857BA-5713-48F1-B83E-44DCCAA8F7F5
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current treatment for colorectal liver metastases
@en
Current treatment for colorectal liver metastases.
@nl
type
label
Current treatment for colorectal liver metastases
@en
Current treatment for colorectal liver metastases.
@nl
prefLabel
Current treatment for colorectal liver metastases
@en
Current treatment for colorectal liver metastases.
@nl
P2860
P356
P1476
Current treatment for colorectal liver metastases
@en
P2093
Evangelos P Misiakos
Gregory Kouraklis
P2860
P304
P356
10.3748/WJG.V17.I36.4067
P407
P577
2011-09-01T00:00:00Z